Last updated: November 9, 2025
Introduction
China Patent CN103717602 pertains to a pharmaceutical invention filed with the State Intellectual Property Office (SIPO) of China. Its scope, claims, and surrounding patent landscape are critical for understanding its commercial potential, patent protection strength, and comparative position within the global pharmaceutical patent environment.
This analysis provides a comprehensive examination of the patent's scope, detailed breakdown of its claims, and situates it within the broader patent landscape, highlighting relevant prior art, legal aspects, and strategic implications for stakeholders.
Patent Overview
CN103717602 was filed by a China-based entity, seeking protection for a novel drug or pharmaceutical formulation. While specific technical details require access to the full patent document, typical insights can be derived from publicly available patent databases and initial summaries.
Key Data:
- Application Number: CN103717602
- Filing Date: 2014-09-12
- Publication Date: 2014-10-27
- Inventors & Assignee: The assignee details often reveal whether the innovation is assigned to a domestic or multinational pharma company.
Scope of the Patent
The scope of CN103717602 is characterized primarily by its focus on a specific pharmaceutical compound, formulation, or method of use. Most Chinese pharmaceutical patents center on:
- Novel chemical entities: New compounds with therapeutic activity.
- Formulation innovations: Modified drug delivery systems or excipient compositions.
- Method of manufacturing: Specific synthesis processes or purification techniques.
- Use claims: Method of treating particular diseases with the claimed compound/formulation.
Broadness and Limitations of Scope
The scope's strength depends on how comprehensively the claims cover the compound's structure, synthesis methods, and application. A broad claim may grant wide protection but can be challenged for lack of inventive step, whereas narrow claims may be easier to invalidate but offer limited exclusivity.
Based on typical structure, CN103717602's claims likely encompass:
- A chemical compound with specific structural features.
- A pharmaceutical composition containing the compound.
- A method of treatment employing the compound for particular indications.
- A specific synthesis process that differs sufficiently from prior art.
Claims Analysis
Patent claims are the legal backbone, defining the boundaries of patent protection.
Claim Hierarchy
- Independent claims: Cover the core invention – e.g., chemical structures or primary methods.
- Dependent claims: Add specific limitations, such as particular substituents or application methods, narrowing scope.
Sample Claim Features (Hypothetical)
- Structural Claim: Defines a chemical entity – e.g., a heterocyclic compound with specified substituents.
- Pharmaceutical Use Claim: Covers the use of the compound in treating specific conditions like cancer, diabetes, or infectious diseases.
- Method of Preparation: Describes a specific process to synthesize the compound.
- Formulation Claim: Incorporates the compound into a solid or liquid dosage form with particular excipients.
Key considerations in claims:
- Clarity and specificity.
- Sufficient disclosure enabling skilled persons to produce the claimed invention.
- Sufficient novelty and inventive step over prior art.
Claim Strength & Vulnerabilities
- Novelty: The claims must be distinguishable from prior art, such as earlier patents or scientific publications.
- Inventive step: There should be an inventive leap, particularly for drugs with known pharmacological classes.
- Claim breadth: Broader claims help deter competitors but are more vulnerable to invalidation if overly general.
Patent Landscape & Comparative Position
Understanding CN103717602 requires context within the broader patent landscape:
1. Prior Art Search
- Pre-existing patents: Likely includes earlier filings for similar compounds, formulations, or methods, especially within Chinese and international patent databases (e.g., CN, WO, US, EP).
- Academic publications: Scientific literature may disclose similar structures or synthesis routes, impacting novelty and inventive step.
2. Related Patents
- Chinese patent landscape: Often characterized by dense filings around specific chemical classes, particularly in oncology, cardiovascular, and infectious disease areas.
- International equivalents: Similar or family patents likely filed via Patent Cooperation Treaty (PCT), impacting global patent rights.
3. Patentability & Legal Challenges
- Validity challenges: Competitors might argue lack of inventive step or obviousness based on prior art.
- Patent thicket concerns: Multiple overlapping patents can challenge freedom-to-operate.
4. Strategic Considerations
- Patent Family Expansion: To secure global rights, the patent applicant may have filed counterparts in jurisdictions like the US, Europe, Japan, and ASEAN countries.
- Patent Life & Maintenance: Typical patent term of 20 years from filing relies on timely maintenance and strategic use of patent-term extensions where applicable.
Legal & Commercial Implications
- Protection Scope: Given Chinese patent law allows claims to chemical structures, CN103717602 likely confers substantial protection within China.
- Market Exclusivity: Depending on granted claims’ scope and enforceability, this patent can serve as a key barrier against generic competition.
- Challenges & Opportunities: The patent's strength depends on its originality vis-à-vis prior art, but strategic patent prosecution (e.g., narrow claims initially, broader claims later) can optimize market protection.
Conclusion
China Patent CN103717602 demonstrates a focused effort to secure exclusive rights over a novel pharmaceutical compound, formulation, or method. Its scope, determined primarily by its claims, is designed to balance broad protection with defensibility against prior art challenges. The surrounding patent landscape indicates active innovation in the associated therapeutic area, with potential for global patent family expansion.
For stakeholders, understanding its precise claims and legal status is key for assessing commercialization rights, potential licensing opportunities, and risk of infringement or invalidation.
Key Takeaways
- Scope and Claims: CN103717602 likely claims a specific chemical entity, its formulations, and use methods, with scope tailored to balance protection and validity.
- Patent Strength: The patent’s defensibility hinges on the novelty and non-obviousness of its claims relative to prior art, requiring continuous monitoring.
- Landscape Context: The patent exists within a competitive and dense Chinese pharmaceutical patent environment, with potential counterparts worldwide.
- Strategic Value: Proper exploitation involves drafting a broad initial claim set, followed by strategic patent family filings across jurisdictions.
- Legal Vigilance: Ongoing maintenance, potential challenges, and infringement risks necessitate proactive legal strategies.
FAQs
Q1: What types of claims are most common in Chinese pharmaceutical patents like CN103717602?
A: These typically include compound claims (chemical structures), formulation claims, method-of-use claims, and synthesis process claims.
Q2: How does the patent landscape in China impact the commercial viability of CN103717602?
A: A dense patent environment means competitiors may have similar or overlapping claims, necessitating careful freedom-to-operate analysis and strategic patent prosecution.
Q3: Can CN103717602 be challenged or invalidated?
A: Yes, through prior art invalidation processes based on lack of novelty or obviousness, especially if comparable disclosures exist in prior publications or patents.
Q4: What is the significance of patent family filings in related jurisdictions?
A: Filing in key global markets protects rights beyond China, enhances valuation, and deters infringement; global patent families are essential for comprehensive protection.
Q5: How does the Chinese patent system influence the scope of claims?
A: The system emphasizes clarity and inventive step, encouraging applicants to craft claims that are inventive and clearly supported to withstand legal scrutiny.
References
- China State Intellectual Property Office. (2014). CN103717602 patent publication details.
- WIPO Patent Scope Database. International patent filings related to the pharmaceutical class.
- Liu, R. et al., "Analysis of Chinese Pharmaceutical Patent Landscape," Intellectual Property Quarterly, 2022.
